🇺🇸 FDA

Company profile · Sponsor

Atara

Atara Biotherapeutics

ATRA · NYSE biotech THOUSAND OAKS, CA, USA
Pipeline
9
Drugs
0
Patents
8

Quick answer

Atara (ATRA) is a biotech company. headquartered in THOUSAND OAKS, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker ATRA
Exchange NYSE
Company type biotech
Headquarters THOUSAND OAKS, CA, USA
SEC CIK 0001604464

Pipeline (9)

Search pipeline →

  1. ATA188

    Atara

    Primary Progressive Multiple Sclerosis

    phase 2 mab terminated

    1 trial

  2. CMV-pp65 CTLs

    Atara

    Cytomegalovirus

    phase 2 mab completed

    1 trial

  3. EBV-specific T cells (EBV-CTLs)

    Atara

    EBV-induced Lymphomas

    phase 2 mab completed

    1 trial

  4. Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)

    Atara

    EBV-induced Lymphomas

    phase 2 mab completed

    1 trial

  5. Tabelecleucel

    Atara

    Nasopharyngeal Carcinoma

    phase 2 mab terminated

    1 trial

  6. ATA3219

    Atara

    Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    phase 1 small molecule terminated

    1 trial

  7. ATA3219

    Atara

    Lupus Nephritis

    phase 1 small molecule terminated

    1 trial

  8. WT1-sensitized T cells

    Atara

    Leukemia

    phase 1 mab completed

    1 trial

  9. cyclophosphamide

    Atara

    Malignant Pleural Mesothelioma (MPM)

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12383572

    Administration of an anti-activin-a compound to a subject

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11925663

    Methods of managing tumor flare in adoptive immunotherapy

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11541070

    Administration of an anti-activin-A compound to a subject

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9968586

    Mast cell stabilizers treatment for systemic disorders

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9962363

    Mast cell stabilizers treatment for systemic disorders

    Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9707206

    Mast cell stabilizers treatment for systemic disorders

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9265749

    Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8501678

    Variant activin receptor polypeptides and uses thereof

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Atara?

Atara (ATRA) is a biotech company. headquartered in THOUSAND OAKS, CA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Atara sponsor?

We track 9 ClinicalTrials.gov-linked programs for Atara, including ATA188 and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Atara company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.